Hypera SA (Brazil) Today
| HYPE3 Stock | BRL 29.38 0.67 2.23% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Hypera SA is selling for under 29.38 as of the 16th of April 2024; that is -2.23% down since the beginning of the trading day. The stock's lowest day price was 29.3. Hypera SA has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Hypera SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of April 2022 and ending today, the 16th of April 2024. Click here to learn more.
It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands dermo-cosmetics products under the Mantecorp Skincare brands and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. The company has 631.94 M outstanding shares. More on Hypera SA
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Hypera Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Hypera SA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Hypera SA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Nicolas Fischer |
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Hypera SA (HYPE3) is traded on Sao Paulo Exchange in Brazil and employs 9,000 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 28.34 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hypera SA's market, we take the total number of its shares issued and multiply it by Hypera SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Hypera SA operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 631.94 M outstanding shares.
Hypera SA has accumulated about 2.24 B in cash with 1.4 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.24.
Check Hypera SA Probability Of Bankruptcy
Ownership AllocationHypera SA has a total of 631.94 Million outstanding shares. Hypera SA secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Hypera Ownership Details
Hypera Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Hypera SA jumping above the current price in 90 days from now is about 97.0%. The Hypera SA probability density function shows the probability of Hypera SA stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Hypera SA has a beta of 0.7869. This usually indicates as returns on the market go up, Hypera SA average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Hypera SA will be expected to be much smaller as well. Additionally, hypera SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Hypera SA to move above the current price in 90 days from now is about 97.0 (This Hypera SA probability density function shows the probability of Hypera Stock to fall within a particular range of prices over 90 days) .
Hypera SA Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Hypera SA market risk premium is the additional return an investor will receive from holding Hypera SA long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Hypera SA. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Hypera SA's alpha and beta are two of the key measurements used to evaluate Hypera SA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.29 | |||
| Standard Deviation | 1.8 | |||
| Variance | 3.23 | |||
| Risk Adjusted Performance | (0.17) |
Hypera Stock Against Markets
Picking the right benchmark for Hypera SA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Hypera SA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Hypera SA is critical whether you are bullish or bearish towards Hypera SA at a given time. Please also check how Hypera SA's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Hypera SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Hypera SA Corporate Directors
Hypera SA corporate directors refer to members of a Hypera SA board of directors. The board of directors generally takes responsibility for the Hypera SA's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Hypera SA's board members must vote for the resolution. The Hypera SA board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Luciana Fleischner | Member of the Board of Directors | Profile | |
| Maria Lacerda | Independent Member of the Board of Directors | Profile | |
| David Coury | Independent Member of the Board of Directors | Profile | |
| Jairo Loureiro | Independent Member of the Board of Directors | Profile |
How to buy Hypera Stock?
Before investing in Hypera SA, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Hypera SA. To buy Hypera SA stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Hypera SA. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Hypera SA stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Hypera SA stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Hypera SA stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Hypera SA, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Hypera SA?
The danger of trading Hypera SA is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Hypera SA is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Hypera SA. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Hypera SA is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hypera SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Hypera SA information on this page should be used as a complementary analysis to other Hypera SA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Hypera Stock analysis
When running Hypera SA's price analysis, check to measure Hypera SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hypera SA is operating at the current time. Most of Hypera SA's value examination focuses on studying past and present price action to predict the probability of Hypera SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hypera SA's price. Additionally, you may evaluate how the addition of Hypera SA to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |